Furthermore, APS reduced inflammatory cytokine levels in intestinal tissue, peripheral blood, and brain tissue, as reflected by modulated IL-4, IL-10, TGF-β, TNF-α, IL-1β, and IL-6 expressions. This evidence concerns the gene TGFB1 and autoimmune polyendocrinopathy.